DexCom
DXCM
Halozyme Therapeutics
HALO
eBay
EBAY
Collegium Pharmaceutical
COLL
New Fortress Energy
NFE
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | 7.56%180.83B | 77.56%168.13B | 131.74%94.69B | -7,947.65%-298.29B | -96.79%3.8B | 14.85%118.35B | 164.92%103.05B | -245.86%-158.74B | -15.97%108.83B | 10.50%129.5B |
Other non cash items | -494.49%-25.05B | -72.53%6.35B | -8.03%23.12B | -28.04%25.14B | 487.62%34.93B | 3,439.33%5.94B | -100.11%-178M | 391.07%167.61B | 254.74%34.13B | -156.86%-22.06B |
Change In working capital | -105.24%-55.01B | 18.11%-26.81B | -154.46%-32.73B | 177.56%60.11B | -2,435.10%-77.5B | -973.43%-3.06B | -99.24%350M | 61.27%46.36B | 182.11%28.74B | -56.59%10.19B |
-Change in receivables | 146.61%29.26B | -200.16%-62.78B | 362.85%62.68B | 95.30%13.54B | -68.23%6.93B | 286.06%21.83B | -247.12%-11.73B | -88.47%7.97B | 1,991.95%69.14B | 128.34%3.31B |
-Change in inventory | 33.53%-25.75B | -195.63%-38.74B | -129.67%-13.1B | 228.60%44.16B | -68.56%-34.34B | 45.68%-20.37B | -250.81%-37.5B | 144.94%24.87B | -29.40%10.15B | 1,311.63%14.38B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -18.88%140.81B | 46.96%173.58B | 384.36%118.11B | -321.11%-41.54B | -87.14%18.79B | 22.09%146.05B | 361.02%119.62B | -123.18%-45.83B | 11.68%197.69B | -15.89%177.01B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Net PPE purchase and sale | -223.78%-112.2B | 51.69%-34.65B | 7.26%-71.73B | 21.51%-77.34B | 16.61%-98.55B | -70.62%-118.18B | -32.59%-69.26B | -949.76%-52.24B | 92.81%-4.98B | 8.86%-69.25B |
Net intangibles purchase and sale | -49.76%-12.88B | 19.24%-8.6B | 14.03%-10.65B | 30.52%-12.39B | -16.06%-17.83B | -33.63%-15.36B | 0.29%-11.5B | -65.97%-11.53B | ---6.95B | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---- | 156.07%3.74B | ---6.67B | ---- | ---- | ---- | ---- |
Net investment purchase and sale | ---- | ---- | ---- | ---- | 9,040.00%457M | -99.27%5M | -72.27%682M | 2,264.42%2.46B | 96.23%104M | -76.02%53M |
Net other investing changes | -39.39%-13.79B | -174.65%-9.89B | 214.33%13.25B | -269.26%-11.59B | 233.96%6.85B | 68.53%-5.11B | -970.94%-16.24B | -93.79%1.87B | 1,251.34%30.03B | -215.35%-2.61B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -161.29%-138.87B | 23.12%-53.15B | 31.78%-69.12B | 4.15%-101.32B | 27.05%-105.71B | -49.24%-144.91B | -32.79%-97.09B | -525.88%-73.12B | 124.07%17.17B | 12.32%-71.33B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | 211.37%60.93B | -934.04%-54.71B | -103.02%-5.29B | 311.46%175.09B | 295.53%42.55B | -793.39%-21.76B | 76.74%-2.44B | 89.78%-10.47B | -6.73%-102.49B | 34.09%-96.02B |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --236.32B | ---- | ---- |
Cash dividends paid | -92,681.25%-14.85B | 23.81%-16M | 40.00%-21M | 99.88%-35M | 0.04%-29.74B | -65.85%-29.75B | -40.64%-17.94B | 21.23%-12.76B | 48.99%-16.19B | ---31.75B |
Net other financing activities | -17.89%-5.31B | -29.23%-4.51B | 10.68%-3.49B | -39.44%-3.9B | 69.78%-2.8B | -1,219.37%-9.26B | 34.02%-702M | 59.44%-1.06B | 18.46%-2.62B | 28.21%-3.22B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 160.90%37.67B | -504.50%-61.87B | -106.08%-10.23B | 1,648.66%168.29B | 112.84%9.62B | -223.67%-74.97B | -111.01%-23.16B | 271.15%210.38B | 6.52%-122.92B | -60.20%-131.49B |
Net cash flow | ||||||||||
Beginning cash position | 16.51%595.93B | 15.04%511.47B | 11.27%444.62B | -18.36%399.59B | -12.45%489.46B | 0.56%559.04B | 20.21%555.91B | 16.92%462.44B | -3.93%395.53B | 13.99%411.7B |
Current changes in cash | -32.36%39.62B | 51.11%58.57B | 52.40%38.76B | 132.90%25.43B | -4.72%-77.3B | -11,617.30%-73.82B | -100.69%-630M | -0.56%91.43B | 456.19%91.94B | -154.91%-25.81B |
Effect of exchange rate changes | 49.32%38.66B | -7.86%25.89B | 44.29%28.1B | 205.49%19.47B | -573.82%-18.46B | 223.02%3.9B | -255.47%-3.17B | 108.14%2.04B | -359.56%-25.03B | 173.95%9.64B |
End cash Position | 13.13%674.2B | 16.51%595.93B | 15.04%511.47B | 11.27%444.62B | -18.36%399.59B | -12.45%489.46B | 0.56%559.04B | 20.21%555.91B | 16.92%462.44B | -3.93%395.53B |
Free cash flow | -85.14%13.96B | 203.77%93.93B | 123.18%30.92B | -20.62%-133.4B | -1,576.54%-110.59B | -79.12%7.49B | 131.52%35.88B | -193.50%-113.83B | 33.18%121.74B | -23.66%91.41B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |